Zantac 150 and Taste - impaired - a phase IV clinical study of FDA data

Summary:

Taste - impaired is reported as a side effect among people who take Zantac 150 (ranitidine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Zantac 75, and have Hypothyroidism.

The phase IV clinical study analyzes which people have Taste - impaired when taking Zantac 150. It is created by eHealthMe based on reports of 5,708 people who have side effects when taking Zantac 150 from the FDA, and is updated regularly.

What is Zantac 150?

Zantac 150 has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 6,519 Zantac 150 users. Check the latest studies of Zantac 150.

What is Taste - impaired?

Taste - impaired is found to be associated with 1,830 drugs and 3,111 conditions by eHealthMe. Check the latest studies of Taste - impaired.

On Jul, 15, 2026

5,708 people reported to have side effects when taking Zantac 150.
Among them, 45 people (0.79%) have Taste - impaired.

Could Zantac 150 cause Taste - impaired?

Among these 45 people:

How long have people been on Zantac 150 when they have Taste - impaired? *

What is the gender of people who have Taste - impaired when taking Zantac 150? *

female: 62.22 %
male: 37.78 %

What is the age of people who have Taste - impaired when taking Zantac 150? *

What are other drugs people take besides Zantac 150? *

What are other side effects people have besides Taste - impaired? *

Belching (release of gas from the digestive tract): 6 people, 13.33%
Chest Pain: 6 people, 13.33%
Dyspnea (difficult or laboured breathing): 5 people, 11.11%
Abdominal Discomfort: 4 people, 8.89%
Abdominal Distension: 4 people, 8.89%
Drug Ineffective: 4 people, 8.89%
Nausea (feeling of having an urge to vomit): 4 people, 8.89%
Diarrhea: 3 people, 6.67%
Cough: 3 people, 6.67%
Lip Swelling: 3 people, 6.67%

What are the existing conditions these people have? *

High Blood Cholesterol: 3 people, 6.67%
High Blood Pressure: 3 people, 6.67%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 6.67%
Tooth Abscess (pus formation in tooth): 2 people, 4.44%
Thyroid Diseases: 2 people, 4.44%
Asthma: 2 people, 4.44%
Belching (release of gas from the digestive tract): 2 people, 4.44%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 2 people, 4.44%
Gastritis (inflammation of stomach): 2 people, 4.44%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 2 people, 4.44%

* Approximation only. Some reports may have incomplete information.

Do you take Zantac 150 and have Taste - impaired?

- Check whether Taste - impaired is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zantac 150:

Zantac 150 (6,519 reports)

Taste - impaired treatments and more:

Taste - impaired (83,126 reports)

Browse all side effects of Zantac 150:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Taste - impaired:

Taste - impaired (1,830 drugs)

Browse all the conditions that are associated with Taste - impaired:

Taste - impaired (3,111 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine hydrochloride (the active ingredients of Zantac 150) and Zantac 150 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.